Nano DDS Mediated Angiogenic Cell and Tissue Delivery
Drug Delivery System · 2026-07-25 · 41 (3) · 194-199
DOI: 10.2745/dds.41.194 ↗At a glance
Journal article in Drug Delivery System, published on 2026-07-25. Written by Kenichi Nagase. 18 references.
Abstract (original language)
Hepatocyte sheet transplantation has attracted attention as a novel therapeutic strategy for intractable liver diseases. The authors have developed basic fibroblast growth factor (bFGF)-releasing nanoparticles designed to promote vascularization within transplanted tissues and thereby enhance engraftment efficiency. By utilizing these nanoparticles, transplantation of hepatocyte sheets was successfully achieved. This review outlines the design strategy of the bFGF-containing nanoparticles.
Cite
APA
Nagase, K. (2026). Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System, 41(3), 194-199. https://doi.org/10.2745/dds.41.194
Vancouver
Nagase K. Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System. 2026;41(3):194-199. doi:10.2745/dds.41.194
BibTeX
@article{Nagase2026,
author = {Nagase, Kenichi},
title = {Nano DDS Mediated Angiogenic Cell and Tissue Delivery},
journal = {Drug Delivery System},
year = {2026},
volume = {41},
number = {3},
pages = {194--199},
doi = {10.2745/dds.41.194}
}
EUVIMED